idelalisib 150 MG Oral Tablet

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

idelalisib 150 MG Oral Tablet

150 MG · Oral Tablet · oral

A form of idelalisib →

idelalisib 150 MG Oral Tablet — Phosphatidylinositol-3-kinase (Pi3K) inhibitors. Strength, form, class, interactions & more.

idelalisib 150 MG Oral Tablet

Active ingredient

Classification

Phosphatidylinositol-3-kinase (Pi3K) inhibitorsKinase Inhibitor

Drug interactions

Idelalisib has significant interactions with strong CYP3A modulators that can affect its concentrations and efficacy.

  • majorstrong CYP3A inhibitors — may increase idelalisib concentrations
  • majorstrong CYP3A inducers — may decrease idelalisib concentrations
  • majorsensitive CYP3A substrates — may increase concentrations of CYP3A substrates

Real-world adverse events (FAERS)

Disease Progression1,225Death802Diarrhoea771Off Label Use572Pneumonia437Pyrexia375Drug Ineffective317Fatigue301

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.